<DOC>
	<DOCNO>NCT00002231</DOCNO>
	<brief_summary>The purpose study see safe give GENEVAX-HIV , new HIV vaccine , HIV-negative volunteer . This study also look vaccine affect immune system volunteer .</brief_summary>
	<brief_title>Safety Effects Giving New HIV Vaccine ( GENEVAX-HIV ) HIV-Negative Volunteers</brief_title>
	<detailed_description>In open-label study , volunteer give intramuscular injection GENEVAX-HIV vaccine use Biojector 2000 . Safety measure immune response assess accordingly .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are 18 60 year old . Are HIVnegative good health . Are able understand infection HIV spread . Agree use effective method birth control study . Exclusion Criteria You eligible study : Have hepatitis B C. Have condition may prevent complete study . Are allergic bupivacaine , vaccine , certain local anesthetic . Have take certain medication receive certain therapy may affect immune system . Have immune system disorder receive therapy immune system disorder . Have expose HIV within 6 month prior study entry . Have receive experimental HIV vaccine experimental treatment within 30 day prior study entry . Have receive blood transfusion within 6 month prior study entry . Abuse alcohol drug uncontrolled psychiatric disorder . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2000</verification_date>
	<keyword>Injections , Intramuscular</keyword>
	<keyword>HIV Antibodies</keyword>
	<keyword>Immunity , Cellular</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Dose-Response Relationship , Immunologic</keyword>
	<keyword>Vaccines , DNA</keyword>
</DOC>